Entries by PR Newswire

, , , , , ,

Taltz receives U.S. FDA approval for nr-axSpA

The U.S. Food and Drug Administration approved a supplemental Biologics License Application for Eli Lilly and Company’s Taltz (ixekizumab) injection 80 mg/mL for the treatment of active non-radiographic axial spondyloarthritis (nr-axSpA) in patients with objective signs of inflammation.

, , , , , , , , ,

Thermo Fisher Scientific Response to COVID-19 Expands to Include New Serology Test

Thermo Fisher Scientific Inc. expanded the company’s response to the COVID-19 pandemic by developing a total antibodies test in collaboration with WuXi Diagnostics and Mayo Clinic.